Selected research
Industry Research
Pharmaceutical Excipient SNAC Industry Research Report 2026
Market perspective
The global Pharmaceutical Excipient SNAC market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pharmaceutical Excipient SNAC is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pharmaceutical Excipient SNAC is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Excipient SNAC is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pharmaceutical Excipient SNAC include Suzhou Tianma Pharmaceutical Group Tianji Biopharmaceutical, Apeloa Pharmaceutical, Hainan Poly Pharm, Novo Nordisk, Kingchem, Jiangsu Southeast Nanomaterials, Apothecon Pharmaceuticals and Actylis Lab, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pharmaceutical Excipient SNAC market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Excipient SNAC Market by Company
Suzhou Tianma Pharmaceutical Group Tianji Biopharmaceutical
Apeloa Pharmaceutical
Hainan Poly Pharm
Novo Nordisk
Kingchem
Jiangsu Southeast Nanomaterials
Apothecon Pharmaceuticals
Actylis Lab
Pharmaceutical Excipient SNAC Segment by Type
Purity 99%
Others
Pharmaceutical Excipient SNAC Segment by Application
Pharmaceuticals
Scientific Research
Pharmaceutical Excipient SNAC Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Excipient SNAC market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Excipient SNAC and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Excipient SNAC.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pharmaceutical Excipient SNAC manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pharmaceutical Excipient SNAC by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pharmaceutical Excipient SNAC in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity 99%
- Others
Applications
- Pharmaceuticals
- Scientific Research
Companies covered
- Suzhou Tianma Pharmaceutical Group Tianji Biopharmaceutical
- Apeloa Pharmaceutical
- Hainan Poly Pharm
- Novo Nordisk
- Kingchem
- Jiangsu Southeast Nanomaterials
- Apothecon Pharmaceuticals
- Actylis Lab
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pharmaceutical Excipient SNAC Market Size (2021-2032)
- 2.2.2 Global Pharmaceutical Excipient SNAC Sales (2021-2032)
- 2.2.3 Global Pharmaceutical Excipient SNAC Market Average Price (2021-2032)
- 2.3 Pharmaceutical Excipient SNAC by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity 99%
- 2.3.3 Others
- 2.4 Pharmaceutical Excipient SNAC by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceuticals
- 2.4.3 Scientific Research
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pharmaceutical Excipient SNAC Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pharmaceutical Excipient SNAC Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Pharmaceutical Excipient SNAC Revenue of Manufacturers (2021-2026)
- 3.4 Global Pharmaceutical Excipient SNAC Average Price by Manufacturers (2021-2026)
- 3.5 Global Pharmaceutical Excipient SNAC Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pharmaceutical Excipient SNAC, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pharmaceutical Excipient SNAC, Product Type & Application
- 3.8 Global Manufacturers of Pharmaceutical Excipient SNAC, Established Date
- 3.9 Global Pharmaceutical Excipient SNAC Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Suzhou Tianma Pharmaceutical Group Tianji Biopharmaceutical
- 4.1.1 Suzhou Tianma Pharmaceutical Group Tianji Biopharmaceutical Company Information
- 4.1.2 Suzhou Tianma Pharmaceutical Group Tianji Biopharmaceutical Business Overview
- 4.1.3 Suzhou Tianma Pharmaceutical Group Tianji Biopharmaceutical Pharmaceutical Excipient SNAC Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Suzhou Tianma Pharmaceutical Group Tianji Biopharmaceutical Pharmaceutical Excipient SNAC Product Portfolio
- 4.1.5 Suzhou Tianma Pharmaceutical Group Tianji Biopharmaceutical Recent Developments
- 4.2 Apeloa Pharmaceutical
- 4.2.1 Apeloa Pharmaceutical Company Information
- 4.2.2 Apeloa Pharmaceutical Business Overview
- 4.2.3 Apeloa Pharmaceutical Pharmaceutical Excipient SNAC Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Apeloa Pharmaceutical Pharmaceutical Excipient SNAC Product Portfolio
- 4.2.5 Apeloa Pharmaceutical Recent Developments
- 4.3 Hainan Poly Pharm
- 4.3.1 Hainan Poly Pharm Company Information
- 4.3.2 Hainan Poly Pharm Business Overview
- 4.3.3 Hainan Poly Pharm Pharmaceutical Excipient SNAC Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hainan Poly Pharm Pharmaceutical Excipient SNAC Product Portfolio
- 4.3.5 Hainan Poly Pharm Recent Developments
- 4.4 Novo Nordisk
- 4.4.1 Novo Nordisk Company Information
- 4.4.2 Novo Nordisk Business Overview
- 4.4.3 Novo Nordisk Pharmaceutical Excipient SNAC Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novo Nordisk Pharmaceutical Excipient SNAC Product Portfolio
- 4.4.5 Novo Nordisk Recent Developments
- 4.5 Kingchem
- 4.5.1 Kingchem Company Information
- 4.5.2 Kingchem Business Overview
- 4.5.3 Kingchem Pharmaceutical Excipient SNAC Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Kingchem Pharmaceutical Excipient SNAC Product Portfolio
- 4.5.5 Kingchem Recent Developments
- 4.6 Jiangsu Southeast Nanomaterials
- 4.6.1 Jiangsu Southeast Nanomaterials Company Information
- 4.6.2 Jiangsu Southeast Nanomaterials Business Overview
- 4.6.3 Jiangsu Southeast Nanomaterials Pharmaceutical Excipient SNAC Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jiangsu Southeast Nanomaterials Pharmaceutical Excipient SNAC Product Portfolio
- 4.6.5 Jiangsu Southeast Nanomaterials Recent Developments
- 4.7 Apothecon Pharmaceuticals
- 4.7.1 Apothecon Pharmaceuticals Company Information
- 4.7.2 Apothecon Pharmaceuticals Business Overview
- 4.7.3 Apothecon Pharmaceuticals Pharmaceutical Excipient SNAC Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Apothecon Pharmaceuticals Pharmaceutical Excipient SNAC Product Portfolio
- 4.7.5 Apothecon Pharmaceuticals Recent Developments
- 4.8 Actylis Lab
- 4.8.1 Actylis Lab Company Information
- 4.8.2 Actylis Lab Business Overview
- 4.8.3 Actylis Lab Pharmaceutical Excipient SNAC Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Actylis Lab Pharmaceutical Excipient SNAC Product Portfolio
- 4.8.5 Actylis Lab Recent Developments
5 Global Pharmaceutical Excipient SNAC Market Scenario by Region
- 5.1 Global Pharmaceutical Excipient SNAC Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pharmaceutical Excipient SNAC Sales by Region: 2021-2032
- 5.2.1 Global Pharmaceutical Excipient SNAC Sales by Region: 2021-2026
- 5.2.2 Global Pharmaceutical Excipient SNAC Sales by Region: 2027-2032
- 5.3 Global Pharmaceutical Excipient SNAC Revenue by Region: 2021-2032
- 5.3.1 Global Pharmaceutical Excipient SNAC Revenue by Region: 2021-2026
- 5.3.2 Global Pharmaceutical Excipient SNAC Revenue by Region: 2027-2032
- 5.4 North America Pharmaceutical Excipient SNAC Market Facts & Figures by Country
- 5.4.1 North America Pharmaceutical Excipient SNAC Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pharmaceutical Excipient SNAC Sales by Country (2021-2032)
- 5.4.3 North America Pharmaceutical Excipient SNAC Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pharmaceutical Excipient SNAC Market Facts & Figures by Country
- 5.5.1 Europe Pharmaceutical Excipient SNAC Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pharmaceutical Excipient SNAC Sales by Country (2021-2032)
- 5.5.3 Europe Pharmaceutical Excipient SNAC Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pharmaceutical Excipient SNAC Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pharmaceutical Excipient SNAC Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pharmaceutical Excipient SNAC Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pharmaceutical Excipient SNAC Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pharmaceutical Excipient SNAC Market Facts & Figures by Country
- 5.7.1 South America Pharmaceutical Excipient SNAC Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pharmaceutical Excipient SNAC Sales by Country (2021-2032)
- 5.7.3 South America Pharmaceutical Excipient SNAC Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Pharmaceutical Excipient SNAC Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pharmaceutical Excipient SNAC Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pharmaceutical Excipient SNAC Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pharmaceutical Excipient SNAC Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pharmaceutical Excipient SNAC Sales by Type (2021-2032)
- 6.1.1 Global Pharmaceutical Excipient SNAC Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Pharmaceutical Excipient SNAC Sales Market Share by Type (2021-2032)
- 6.2 Global Pharmaceutical Excipient SNAC Revenue by Type (2021-2032)
- 6.2.1 Global Pharmaceutical Excipient SNAC Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pharmaceutical Excipient SNAC Revenue Market Share by Type (2021-2032)
- 6.3 Global Pharmaceutical Excipient SNAC Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pharmaceutical Excipient SNAC Sales by Application (2021-2032)
- 7.1.1 Global Pharmaceutical Excipient SNAC Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Pharmaceutical Excipient SNAC Sales Market Share by Application (2021-2032)
- 7.2 Global Pharmaceutical Excipient SNAC Revenue by Application (2021-2032)
- 7.2.1 Global Pharmaceutical Excipient SNAC Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pharmaceutical Excipient SNAC Revenue Market Share by Application (2021-2032)
- 7.3 Global Pharmaceutical Excipient SNAC Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pharmaceutical Excipient SNAC Value Chain Analysis
- 8.1.1 Pharmaceutical Excipient SNAC Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pharmaceutical Excipient SNAC Production Mode & Process
- 8.2 Pharmaceutical Excipient SNAC Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pharmaceutical Excipient SNAC Distributors
- 8.2.3 Pharmaceutical Excipient SNAC Customers
9 Global Pharmaceutical Excipient SNAC Analyzing Market Dynamics
- 9.1 Pharmaceutical Excipient SNAC Industry Trends
- 9.2 Pharmaceutical Excipient SNAC Industry Drivers
- 9.3 Pharmaceutical Excipient SNAC Industry Opportunities and Challenges
- 9.4 Pharmaceutical Excipient SNAC Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst